Hasten Biopharma acquires commercial rights in China for Roche's antibiotic Rocephin

Hasten Biopharmaceutic has acquired the commercial rights in China for Rocephin, a long-acting, broad spectrum ceph...

May 5, 2023 | Friday | News
How Radiopharmaceuticals Are Transforming Cancer Treatment

A key goal for any innovative cancer treatment is the ability to deliver an anti-cancer agent directly to the tumour and...

May 3, 2023 | Wednesday | Analysis
China Emerges as New APAC Pharma R&D Engine

With the continued emergence of China as a global hub for biopharma innovation, companies from the country are now looki...

May 3, 2023 | Wednesday | Opinion
Investment in deeptech companies soars to propel APAC pharma R&D

The pandemic put severe pressure on many healthcare systems and pharma companies, indirectly providing impetus for large...

May 3, 2023 | Wednesday | Opinion
$15 Bn Pharma R&D Spends Rocks APAC

Earlier seen as a generic powerhouse, Asia is now an important hub for pharma R&D innovation. The total gross expend...

May 3, 2023 | Wednesday | Analysis
Japan's Astellas Pharma acquires US-based Iveric Bio for $5.9 B

Japan headquartered Astellas Pharma Inc. and US-based Iveric Bio have entered into a definitive agreement under which As...

May 1, 2023 | Monday | News
India, Korea strengthen ties to boost pharma sector

The Indian Drug Manufacturers' Association (IDMA) and the Korea Pharmaceutical and Bio-Pharma Manufacturers Associ...

April 27, 2023 | Thursday | News
Bostik unveils solvent-free laminating adhesive for pharma industries in China

Bostik, a leading global adhesive specialist for industrial, construction and consumer markets, has launched HERBERTS ...

April 26, 2023 | Wednesday | News
Taiwan approves Japan-based Chugai Pharma's drug for COVID-19 treatment

Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Japan's Chugai Pharmaceutical, has obtained an import drug licen...

April 26, 2023 | Wednesday | News
Bridgewest to commercialise sterile injectable drugs under LumaCina biz unit in Australia

Global private investment firm, Bridgewest Group, has established LumaCina business unit under Bridgewest Perth Pha...

April 26, 2023 | Wednesday | News
China marks beginning of new treatment for primary immunoglobulin A nephropathy

Everest Medicines, China-based biopharmaceutical startup focused on the development, manufacturing and commercialisation...

April 24, 2023 | Monday | News
India's Natco Pharma invests $3 M to set up subsidiary in Indonesia

Indian firm Natco Pharma has announced plans of setting up of a subsidiary in Indonesia with an investment of up to...

April 21, 2023 | Friday | News
Dion Warren chairs Takeda's Multi-Country Organization (MCO), India & Southeast Asia

Takeda Pharmaceuticals has named Dion Warren as Head of the I-SEA Multi-Country Organization (MCO), effective April...

April 21, 2023 | Friday | News
Eli Lilly and Mitsubishi Tanabe launch new diabetes treatment in Japan

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation (MTPC) have announced the launch of Mounjaro subcutaneous...

April 21, 2023 | Friday | News
Japan's Shin Nippon Biomedical Labs buys American firm Satsuma Pharma

US-based Satsuma Pharmaceuticals has entered into a definitive agreement to be acquired by Japanese firm Shin Nippon Bio...

April 20, 2023 | Thursday | News
Eli Lilly fosters diverse talent pipeline for high-tech manufacturing jobs in US

American pharmaceutical firm Eli Lilly and Company is investing an additional $1.6 billion and add another 200...

April 18, 2023 | Tuesday | News
West Pharma announces extension of complete containment solution in Korea

West Pharmaceutical Services, Inc. has announced the extension of its complete containment solution, Ready Pack, in...

April 18, 2023 | Tuesday | News
Dr Bassem Elmankabadi joins Taiwan's Foresee Pharma as Senior VP- Clinical Development

Taiwan's Foresee Pharmaceuticals Co. has announced that Bassem Elmankabadi, M.D. joins Foresee as a Senior Vice Pre...

April 18, 2023 | Tuesday | News
Merck acquires Prometheus Biosciences for $10.8 B to strengthen immunology pipeline

American pharmaceutical firm Merck, known as MSD outside the United States and Canada, and US-based startup Prometheus B...

April 17, 2023 | Monday | News
Korean firm Standigm announces Younsung Choo as Chief Executive Officer

South Korea based Standigm, a company using artificial intelligence (AI) technology for drug discovery and developm...

April 13, 2023 | Thursday | News
Standigm and Institut Pasteur Korea identify drug candidates for resistant tuberculosis

Standigm, a South Korea-based startup using artificial intelligence (AI) technology for drug discovery and development, ...

April 6, 2023 | Thursday | News
US CDMOs seek to address capacity challenges and supply chain contingencies

Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to I...

April 5, 2023 | Wednesday | News
Luye Pharma, Duopharma to expand accessibility of cholesterol management products in Malaysia

China-based Luye Pharma Group has entered an agreement with Duopharma Marketing Sdn Bhd, a wholly-owned subsidiary of Du...

April 5, 2023 | Wednesday | News
Largest ever edition of analytica Vietnam set to take place on April 19-21, 2023

The 7th analytica Vietnam 2023 is set to take place from April 19-21, 2023, at the Saigon Exhibition and Convention Cent...

April 4, 2023 | Tuesday | News
China gives nod to biosimilar of Denosumab for osteoporosis in postmenopausal women

Mabwell, a China-based biopharmaceutical startup, has announced that the Denosumab solution for injection which is devel...

April 4, 2023 | Tuesday | News